Virtual Reality in Patients With Pulmonary Hypertension: A Randomized Controlled Trial
Enrolling by invitation · Not applicable
Conditions studied: Idiopathic Pulmonary Arterial Hypertension
In brief
The goal of this research is to investigate the effectiveness of exercise administered via immersive virtual reality in patients with pulmonary hypertension, thereby contributing to the existing literature on this subject. The main question is whether exercises delivered via immersive virtual reality are effective to improve physical performance, functional capacity, dyspnea, muscle strength, fatigue, quality of life, depression and anxiety.
Key facts
- Study ID
- NCT07558460
- Run by
- Istanbul University - Cerrahpasa
- People needed
- 32
- Starts
- 2026-01-31
- Expected to finish
- 2027-01-01
- Last updated by the study team
- 2026-04-30
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of Idiopathic Pulmonary Arterial Hypertension,
- Stable pharmacological treatment for the past 3 months,
- Hemodynamic and clinical stability for at least the past three months,
- Age of 18-65,
- Voluntary participation in the study and signing the informed consent form,
- Being classified in the World Health Organization-Functional Classification I, II or III.
You may not qualify if…
- The presence of an orthopedic or neurological problem that will affect functional tests and muscle strength measurement,
- Acute decompensated heart failure,
- Unstable angina pectoris,
- Uncontrolled hypertension,
- The presence of problems that hinder communication,
- Dizziness, vertigo,
- Severe visual impairment,
Where it is running
- Istanbul University-Cerrahpaşa/ Cardiology Institute — Istanbul, Fatih, Turkey (Türkiye)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.